Thyme Care was featured in HIT Consultant after raising $97 million to scale its value-based oncology and AI infrastructure. HIT Consultant The article notes that the funding, backed by both existing and new strategic investors (e.g. CVS Health Ventures, a16z Bio + Health, Morgan Health, Humana, Texas Oncology, Memorial Hermann), brings total capital raised to $275 million. HIT Consultant It also highlights that Thyme Care has become profitable and now manages over $5 billion in oncology spend, serving 8 million people through Medicare, commercial, and employer contracts.
What You Should Know:
– Thyme Care, a value-based cancer care enabler secures $97M in Series D funding, bringing its total capital raised to $275M.
The funding round was overwhelmingly backed by strategic investors, including current investors such as CVS Health® Ventures, Foresite Capital, and a16z Bio + Health, with new strategic investors including Morgan Health (JPMorganChase), Humana, Texas Oncology, and Memorial Hermann Health System.
– The company also achieved profitability and now manages more than $5B in oncology spend. This landmark year of growth includes extending access to 8 million people nationwide through new Medicare, commercial, and employer contracts.
Since its founding in 2020, Thyme Care has worked to create an integrated oncology infrastructure that reduces friction across the system. The model is built on aligning incentives through partnerships with payers so that the best care for patients is also the most sustainable for the system. Thyme Care works closely with more than 1,000 oncologists nationwide.
According to CEO and Co-Founder Robin Shah, Thyme Care was founded to change a system “not designed for people with cancer”. The platform achieves this by:
For patients, this translates to earlier interventions, fewer delays, and continuous support throughout the cancer journey.
Artificial intelligence, already deeply integrated into Thyme Care’s model, is becoming a critical accelerant for the company’s growth. By automating documentation, surfacing real-time insights, and synthesizing complex patient data, AI reduces the cognitive load on care teams. The result is a system that allows providers to focus on people rather than paperwork and makes high-quality, scalable cancer care possible.
Thyme Care’s model has demonstrated systemic transformation across three key areas...